RNA m⁶A modification and its regulatory factors are altered in granulosa cells from women with PMOS

Study limitation reported by the research below: “The paper uses the term 'PMOS' (Polyendocrine Metabolic Ovarian Syndrome) rather than the standard 'PCOS' (Polycystic Ovary Syndrome); this appears to be either a novel rebranding or a terminology error — clinicians should be aware this likely refers to PCOS.”